Pulido Ortega, Federico
No evidence for evolution of protease inhibitor resistance from standard genotyping, after three years of treatment with darunavir/ritonavir, with or without nucleoside analogues. [carta] - AIDS Research and Human Retroviruses, 2012 - 28(10):1167-9.
Formato Vancouver:
Pulido F, Arribas J, Hill A, Moecklinghoff C. No evidence for evolution of protease inhibitor resistance from standard genotyping, after three years of treatment with darunavir/ritonavir, with or without nucleoside analogues. AIDS
Res Hum Retroviruses. 2012 Oct;28(10):1167-9.
PMID: 22380531
Contiene 15 referencias
No evidence for evolution of protease inhibitor resistance from standard genotyping, after three years of treatment with darunavir/ritonavir, with or without nucleoside analogues. [carta] - AIDS Research and Human Retroviruses, 2012 - 28(10):1167-9.
Formato Vancouver:
Pulido F, Arribas J, Hill A, Moecklinghoff C. No evidence for evolution of protease inhibitor resistance from standard genotyping, after three years of treatment with darunavir/ritonavir, with or without nucleoside analogues. AIDS
Res Hum Retroviruses. 2012 Oct;28(10):1167-9.
PMID: 22380531
Contiene 15 referencias
